Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary α-Amylase as a Non-Invasive Biomarker of PRF-Enhanced Wound Healing After Third Molar Surgery

NCT07600619 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.

NCT NCT07600619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07600619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary α-Amylase as a Non-Invasive Biomarker of PRF-Enhanced Wound Healing After Third Molar Surgery
Lead sponsor
Hasanuddin University
Phase
Not applicable
Overall status
Completed
Start date
May 12, 2024
Completion date
December 22, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impacted mandibular third molar, platelet-rich fibrin (prf), postoperative wound healing, salivary alpha amylase